Journal List > Nat Prod Sci > v.25(2) > 1129687

Choi, Jeong, Jang, Lee, Kwon, Yoon, Shin, and Yang: Simultaneous Analysis of Four Standards of The Herbal Formula, DF-02, of Ephedra intermedia and Rheum palmatum, using by High Performance Liquid Chromatography-Ultraviolet Detector (HPLC-UVD)

Abstract

The herbal formula, DF-02, consisting of Ephedra intermedia and Rheum palmatum are used for the treatment of the metabolic diseases such as obesity and liver fibrosis in Korean local clinics. We aimed to develop the simultaneous analytical conditions for four standards, (+)-pseudoephedrine (PSEP) and (−)-ephedrine (EP) for E. intermedia, and aloe-emodin (AE) and chrysophanol (CP) for R. palmatum using HPLC-UV techniques. The validated conditions yielded the high precision (relative standard deviation (RSD) < 3.65%) and the recoveries (94 – 106%) using the calibration curves with high linearity (R2 > 0.9994). As a result, four standards of DF-02 were simultaneously determined under the developed method, which will be utilized for the quality control or evaluation of DF-02 and many herbal preparations containing E. intermedia and R. palmatum.

Introduction

The herbal formula, DF-02, comprised of two traditional medicinal herbs, Ephedra intermedia Schrenk and Rheum palmatum Linne and is currently being used for the treatment of diabetes, obesity and the metabolic diseases in local Korean oriental medicine clinics.1 E. intermedia is one of Ephedra spp. native to Northeastern China, Russia, and Mongolia and has been used for the treatment of asthma and cough in Eastern Asia for a long time.2 Ephedra spp. have ephedra alkaloids such as (+)-pseudoephedrine (PSEP), (−)-ephedrine (EP), (+)-norpseudoephedrine and (−)-norephedrine which are pharmacologically sympathomimetic agonists acting on both α- and β-adrenergic receptors.34 Recently the CNS stimulatory action of Ephedra spp. has been suggested as the therapeutic agents for the treatment of obesity.5 R. palmatum, a perennial plant, are used for purgation and purging heat, promote blood circulation and remove blood stasis in East Asian countries for a long time.67 Anthraquinone derivatives, such as emodin, aloe-emodin (AE), chrysophanol (CP) and physcion, are the pharmacologically active components as naturally occurring laxatives of R. palmatum. In this study, we developed the simultaneous analytical method and validation of four standards, PSEP, EP, AE and CP, (Fig. 1) in DF-02 formula.

Experimental

Chemicals

PSEP and EP were gifted from Dr. Sang Hyun Sung, a professor of College of Pharmacy, Seoul National University. AE, CR and sodium dodecyl sulfate (SDS) were purchased from Sigma-Aldrich (St. Louis, MO, USA) and HPLC-grade water and acetonitrile from TEDIA (Fairfield, OH, USA).

Plant materials

The air-dried plants, E. intermedia (1 kg) and R. palmatum (1 kg), were provided from Dr. Soon Shik Shin, a professor of the Department of Korean medicine, Dong-eui University and identified by Dr. Yong Soo Kwon, a professor of College of Pharmacy, Kangwon National University. Two herbs were deposited in the Herbarium of College of Pharmacy, Kangwon National University (KNUPH-EI-1 and KNUPH-RP-1).

Extraction of DF-02 formula

DF-02 formula was prepared by the patented technologies. Brifely, two herbs E. intermedia and R. palmatum were cut to 2 – 3 cm, proportionally combined and mixed in the proportion of 9 (E. intermedia) and 1 (R. palmatum). The mixture was soaked 30% ethanol and extracted (3 × 3 h) using Soxhlet technique at 85 ℃. The mixture was then filtered and evaporated to dryness using a rotary evaporator. After freeze-drying to a powder (20 mg), it was dissolved in 1 mL of 70% methanol for the analyses. All the samples were filtered through a 0.45 µm polyvinylidene fluoride membrane filter before injection into a high performance liquid chromatography (HPLC).

Chromatographic conditions

HPLC system was carried out on Agilent 1260 Infinity system consisting of 1260 quaternary pump, autosampler and multiple wavelength detector (Agilent Technologies Mfg GmbH&Co.KG, Waldbronn, Germany) and a Hector-M C18-M51002546 column (250 mm × 4.6 mm; 5 µm, RStech, Daejeon, Korea), and all chromatograms were measured at 210 nm and 254 nm with the mixtures of HPLC-grade H2O buffered with 25 mM SDS (solvent A) and acetonitrile (solvent B) at 30 ℃ temperature. The gradient elution condition was 60% solvent A (0 – 25 min) and 60 – 40% solvent A (25 – 35 min) and 40% solvent A (35 – 40 min) and 40 – 20% solvent A (40 – 50 min) and 20% solvent A (50 – 60 min) with the flow rate of 1.0 mL/min, and aliquots of 10 µL were injected using the autosampler for the analyses.

Method validation

The validation was performed in terms of linearity, limit of detection (LOD), limit of quantitation (LOQ), precision and accuracy were using the software (OpenLAB CDS ChemStation Edition - 1260 HPLC) according to the ICH guide line. To demonstrate the linearity, PSEP (10, 25, 50, 100 and 250 µg/mL), EP (25, 100, 250, 500 and 1000 µg/mL), AE (1, 5, 10, 25 and 250 µg/mL) and CP (0.5, 2.5, 12.5, 25 and 250 µg/mL) were respectively prepared based on the content of standard compounds in DF-02 formula. The linearity was measured through correlation coefficients (R2). LOD and LOQ were calculated by the formula, 3.3 × (∂ / S) and 10 × (∂ / S), respectively. Herein, ∂ is the standard deviation of the y-axis value of the linear equation of the calibration curve and S is the slope value of the linear equation of the calibration curve. For the precision results, intra-day and inter-day tests were performed under the optimized HPLC analytical method. The recovery test was used to investigate the accuracy of this analysis method, the standard solutions with three different concentrations (PSEP (50, 100 and 250 µg/mL), EP (500, 750 and 1000 µg/mL), AE (2, 5 and 10 µg/mL) and CP (0.5, 2.5 and 12.5 µg/mL)) were added to DF-02 formula dissolved in 100% MeOH (20 mg/mL) and analyzed in triplicate. And these three different concentration solutions (added PSEP, EP, AE and CP) were used to intra-day and inter-day tests. The intra-day test of four compounds were tested in three different concentrations within 1 day and the inter-day test were conducted over 3 days (first, third and fifth day), respectively. The relative standard deviation (RSD) was taken as a measure of repeatability.

Result and Discussion

PSEP and EP for E. intermedia, and AE and CP for R. palmatum were known as the major constituents with the pharmacological activities for each herb and were applied as the maker compounds to validate DF-02 formula which were perepared with two herbs (Fig. 1). Because PSEP and EP are alkaloid-type compounds with a secondary amine group and are positively charged, the acidic buffers, such as formic acid and phosphric acid, were applied to form netural ion pair complexes for the better separation. Among the buffer system, the solvent system buffered with 25 mM SDS was found to be suitable for reproducibility in routine analysis, without the deterioration of peaks for PSEP and EP in the previous studies.8 Also the solvent system buffered with SDS was suitable for the chromatographic separation of less polar compounds, AE and CP, in the column (Fig. 2). In the optimized solvent condition, four standards, AE, PSEP, EP and CP were detected at 16.9, 27.3, 29.1 and 47.5 min, respectively.
The calibration curves for four standards showed the good linearity with high correlation coefficients (R2 = 0.9994), and the LOD and LOQ values were in the range of 0.6~3.6 ng/mL and 1.7~10.7 ng/mL, respectively (Table 1). SDS has a negative ion allowing to form neutral ion pair complexes with a positive ion of EP and PSEP. Also, the AE and CP standards were well retained and give higher resolution in the column. The low quantity of R. palmatum in DF-02 formula and low extraction efficiency of less-polar AE and CP under 30% EtOH solvent hindered the detection of AE and CP in DF-02 formula at 210 nm, but they were simultaneously detected at 254 nm using multi-channel function of UV detector. (Fig. 2) As a result, the optimized analytical condition was applied to the further validation study. The precision of the optimized analytical methods was confirmed by RSDs of less than 2.53% for the intra-day and 3.65% for the inter-day tests. Also, four standards were well-recovered with high yields of 94.3~106.2%, respectively. (Table 2) Under the optimized analytical conditions, the contents of four standards in DF-02 formula were determined as 6.09 mg/g for PSEP, 42.91 mg/g for EP, 0.11 mg/g for AE and 0.06 mg/g for CP, respectively. In this study, we successfully established the simultaneous determination method of four chemical markers, EP, PSEP, AE and CP, of DF-02 formula consisting of E. intermedia and R. palmatum.

Figures and Tables

Fig. 1

The structures of (+)-pseudoephedrine (1), (−)-ephedrine (2), aloe-emodin (3) and chrysophanol (4).

nps-25-111-g001
Fig. 2

HPLC chromatogram of DF-02 formula and the standards obtained at UV 210 (A) and 254 (B) nm: (a) DF-02 formula (20 mg/mL), (b) (+)-pseudoephedrine, (c) (−)-ephedrine, (d) aloe-emodin and (e) chrysophanol. Detailed experimental conditions are described in the Experimental section.

nps-25-111-g002
Table 1

The linear regression curves, LODs and LOQs of four standards.

nps-25-111-i001

a PSEP: (+)-pseudoephedrine, EP: (−)-ephedrine, AE: aloe-emodin, CP: chrysophanol

Table 2

Precision and accuracy test of four standards

nps-25-111-i002

a PSEP: (+)-pseudoephedrine, EP: (−)-ephedrine, AE: aloe-emodin, CP: chrysophanol

Acknowledgments

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (No. HI15C0075).

References

1. Jeong B, Choi SY, Jang HS, Yoo G, Kim SH, Kim J, Kwon YS, Roh JS, Yoon Y, Shin SS. Nat Prod Sci. 2017; 23:9–15.
2. Kee CH. The Pharmacology of Chinese Herbs. U.S.A.: CRC Press;1999. p. 308.
3. Yamada I, Goto T, Takeuchi S, Ohshima S, Yoneyama K, Shibuya T, Kataoka E, Segawa D, Sato W, Dohmen T, Anezaki Y, Ishii H, Ohnishi H. Cytokine. 2008; 41:293–301.
4. Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Schaneberg BT, Khan IA, Feller DR. J Pharmacol Exp Ther. 2007; 322:214–221.
5. Fleming RM. Expert Opin Drug Saf. 2008; 7:749–759.
crossref
6. Chen DC, Wang L. Chin J Traumatol. 2009; 12:365–369.
7. Barceloux DG. Dis Mon. 2009; 55:403–411.
8. Sheu S, Huang M. J Food Drug Anal. 2000; 8:337–341.
TOOLS
Similar articles